Personal information

No personal information available

Activities

Collapse all

Employment (1)

Prinses Máxima Centrum voor Kinderoncologie: Utrecht, Utrecht, NL

2018-06-01 to present | MD, PhD (Hemtology-Oncology)
Employment
Source: Self-asserted source
Auke Beishuizen

Education and qualifications (1)

Erasmus MC Sophia: Rotterdam, Zuid-Holland, NL

1999-07-01 to 2018-06-01 | MD, PhD (Pediatric Oncology/ Hematology)
Education
Source: Self-asserted source
Auke Beishuizen

Works (11)

Semen analysis and reproductive hormones in boys with classical Hodgkin lymphoma treated according to the EuroNet-PHL-C2 protocol

Human Reproduction
2024-11-01 | Journal article
DOI: 10.1093/humrep/deae204
Contributors: K C E Drechsel; S L Broer; H M K van Breda; F S Stoutjesdijk; E van Dulmen-den Broeder; A Beishuizen; W H Wallace; D Körholz; C Mauz-Körholz; D Hasenclever et al.
Source: check_circle
Crossref

The impact of treatment for childhood classical Hodgkin lymphoma according to the EuroNet-PHL-C2 protocol on serum anti-Müllerian Hormone

Human Reproduction
2024-08-01 | Journal article
DOI: 10.1093/humrep/deae112
Contributors: K C E Drechsel; S L Broer; F S Stoutjesdijk; E van Dulmen-den Broeder; A Beishuizen; W H Wallace; D Körholz; C Mauz-Körholz; D Hasenclever; M Cepelova et al.
Source: check_circle
Crossref

Fertility-Preserving Treatments and Patient- and Parental Satisfaction on Fertility Counseling in a Cohort of Newly Diagnosed Boys and Girls with Childhood Hodgkin Lymphoma

Cancers
2024-05-31 | Journal article
DOI: 10.3390/cancers16112109
Contributors: Katja C. E. Drechsel; Irene M. IJgosse; Sofie Slaats; Lisanne Raasen; Francis S. Stoutjesdijk; Eline van Dulmen-den Broeder; W. Hamish Wallace; Auke Beishuizen; Dieter Körholz; Christine Mauz-Körholz et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Large B-cell lymphoma-IRF4+ in children and young people: time to reduce chemotherapy in a rare malignant mature B-cell neoplasm?

Blood Advances
2024-03-26 | Journal article
DOI: 10.1182/bloodadvances.2023012109
Contributors: Minke Huibers; Oussama Abla; Mara Andrés; Olga Balagué; Auke Beishuizen; Elisa Carraro; Alan Chiang; Monika Csóka; Bianca-Andreea David; Maëlle de Ville de Goyet et al.
Source: check_circle
Crossref

NOTCH1 fusions in pediatric T-cell lymphoblastic lymphoma: a high-risk subgroup with CCL17 (TARC) levels as diagnostic biomarker

2024-02-02 | Preprint
DOI: 10.1101/2024.01.31.24301517
Contributors: Emma Kroeze; Michelle M Kleisman; Lennart A Kester; Marijn A Scheijde-Vermeulen; Edwin Sonneveld; Jessica GC Buijs-Gladdines; Melanie M Hagleitner; Friederike AG Meyer-Wentrup; Margreet A Veening; Auke Beishuizen et al.
Source: check_circle
Crossref

Significance of E-lesions in Hodgkin lymphoma and the creation of a new consensus definition: a report from SEARCH

Blood Advances
2023-10-24 | Journal article
DOI: 10.1182/bloodadvances.2023010024
Contributors: Eline A. M. Zijtregtop; Jamie Zeal; Monika L. Metzger; Kara M. Kelly; Christine Mauz-Koerholz; Stephan D. Voss; Kathleen McCarten; Jamie E. Flerlage; Auke Beishuizen
Source: check_circle
Crossref

Reproductive ability in survivors of childhood, adolescent, and young adult Hodgkin lymphoma: a review

Human Reproduction Update
2023-07-05 | Journal article
DOI: 10.1093/humupd/dmad002
Contributors: Katja C E Drechsel; Maxime C F Pilon; Francis Stoutjesdijk; Salena Meivis; Linda J Schoonmade; William Hamish B Wallace; Eline van Dulmen-den Broeder; Auke Beishuizen; Gertjan J L Kaspers; Simone L Broer et al.
Source: check_circle
Crossref

Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial

Blood Advances
2023-02-28 | Journal article
DOI: 10.1182/bloodadvances.2022008802
Contributors: G. A. Amos Burke; Luciana Vinti; Edita Kabickova; Auke Beishuizen; Nurdan Tacyildiz; Anne Uyttebroeck; Hyoung Jin Kang; Flavio Luisi; Véronique Minard-Colin; Birgit Burkhardt et al.
Source: check_circle
Crossref

Machine Learning Logistic Regression Model for Early Decision Making in Referral of Children with Cervical Lymphadenopathy Suspected of Lymphoma

Cancers
2023-02-12 | Journal article
DOI: 10.3390/cancers15041178
Contributors: Eline A. M. Zijtregtop; Louise A. Winterswijk; Tammo P. A. Beishuizen; Christian M. Zwaan; Rutger A. J. Nievelstein; Friederike A. G. Meyer-Wentrup; Auke Beishuizen
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Nivolumab, Brentuximab Vedotin, +/- Bendamustine For R/R Hodgkin Lymphoma in Children, Adolescents, and Young Adults

Blood
2022-12-23 | Journal article
DOI: 10.1182/blood.2022017118
Contributors: Paul Harker-Murray; Christine Mauz-Körholz; Thierry M Leblanc; Maurizio Mascarin; Gérard Michel; Stacy Cooper; Auke Beishuizen; Kasey J. Leger; Loredana Amoroso; Salvatore Buffardi et al.
Source: check_circle
Crossref

Progress against non-Hodgkin's lymphoma in children and young adolescents in the Netherlands since 1990: Stable incidence, improved survival and lower mortality

European Journal of Cancer
2022-03 | Journal article
DOI: 10.1016/j.ejca.2021.12.010
Contributors: Ardine M.J. Reedijk; Auke Beishuizen; Jan Willem W. Coebergh; Bianca A.W. Hoeben; Leontien C.M. Kremer; Konnie M. Hebeda; Rob Pieters; Jan L.C. Loeffen; Henrike E. Karim-Kos
Source: check_circle
Crossref
How many people are using ORCID?